Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: A randomized, controlled trial

Journal of Clinical Oncology

Volumn 27, Issue 36, 2009, Pages 6191-6198

  Molassiotis, Alex ^a   Brearley, Sarah ^a   Saunders, Mark ^a   Craven, Olive ^a   Wardley, Andrew ^a   Farrell, Carole ^a   Swindell, Ric ^a   Todd, Chris ^a   Luker, Karen ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; DOCETAXEL; IRINOTECAN; MITOMYCIN; NAVELBINE; OXALIPLATIN; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL;

ADULT; AGED; ANXIETY; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER FATIGUE; CANCER PAIN; CLINICAL TRIAL; COLORECTAL CANCER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HAND FOOT SYNDROME; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOME CARE; HOSPITAL PATIENT; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; METHODOLOGY; MIDDLE AGED; NURSING; ORAL DRUG ADMINISTRATION; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 74949086115     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.6755     Document Type: Article

References (43)

1. O'Neill VJ, Twelves CJ: Oral cancer treatment: Developments in chemotherapy and beyond. Br J Cancer 87:933-937, 2002
2. O'Shaughnessy J, Miles D, Vukelja S, et al: Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: Phase III trial results. J Clin Oncol 20:2812-2823, 2002
3. Hoff PM, Ansari R, Batist G, et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. J Clin Oncol 19:2282-2292, 2001
4. Van Cutsem E, Twelves C, Cassidy J, et al: Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: Results of a large phase III study. J Clin Oncol 19:4097-4106, 2001
5. Roche. Xeloda product information, April 2006. http://www.rocheusa.com/ products/xeloda/ pi.pdf
6. Borner MM, Dietrich D, Stupp R, et al: Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced metastatic colorectal cancer. J Clin Oncol 20:1759-1766, 2002
7. McCorkle R, Benoliel JQ, Donaldson G, et al: A randomized clinical trial of home nursing for lung cancer patients. Cancer 64:1375-1382, 1989
8. Smeenk FW, de Witte LP, Nooyen IW, et al: Effects of transmural care on coordination and continuity of care. Patient Educ Couns 41:73-81, 2000
9. McCorkle R, Strumpf N, Nuamah I, et al: A specialized home care intervention improves survival among older postsurgical cancer patients. J Am Geriatr Soc 48:1707-1713, 2000
10. Bourbonniere M, Kagan SH: Nursing intervention and older adults who have cancer: Specific science and evidence based practice. Nurs Clin North Am 39:529-543, 2004
11. Smeenk FWJM, van Haastregt JCM, de Witte LP, et al: Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: A systematic review. BMJ 316:1939-1944, 1998
12. Marsé H, Van Cutsem E, Grothey A, et al: Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs 8:S16-S30, 2004 (suppl 1)
13. Lassere Y, Hoff P: Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). Eur J Oncol Nurs 8:S31-S40, 2004 (suppl 1)
14. Webster-Gandy JD, How C, Harrold K: Palmar-plantar erythrodysesthesia (PPE): A literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs 11:238-246, 2007
15. Worthington HV, Clarkson JE, Eden OB: Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev Oct 17, 2007, 4:CD000978, 2007
16. European Oncology Nursing Society: Oral Mucositis Guidelines-Guidelines Implementation toolkit.http://www.cancernurse.eu/documents/EONS ClinicalGuidelinesSection4-en.pdf 2007
17. Harris DJ, Eilers J, Harriman A, et al: Putting evidence into practice: Evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs 12:141-152, 2008
18. Lotfi-Jam K, Carey M, Jefford M, et al: Nonpharmacologic strategies for managing common chemotherapy adverse effects: A systematic review. J Clin Oncol 26:5618-5629, 2008
19. Molassiotis A, Helin AM, Dabbour R, et al: The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients. Complement Ther Med 15: 3-12, 2007
20. Ezzo J, Streitberger K, Schneider A: Cochrane systematic reviews examine P6 acupuncture-point stimulation for nausea and vomiting. J Altern Complement Med 12:489-495, 2006
21. Naeim A, Dy SM, Lorenz KA, et al: Evidencebased recommendations for cancer nausea and vomiting. J Clin Oncol 26:3903-3910, 2008
22. Mock V, Frangakis C, Davidson NE, et al: Exercise manages fatigue during breast cancer treatment: A randomized controlled trial. Psychooncology 14:464-477, 2005
23. Molassiotis A, Sylt P, Diggins H: The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: A randomised controlled trial. Complement Ther Med 15:228-237, 2007
24. Payne JK, Held J, Thorpe J, et al: Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 35:635-642, 2008
25. Berger AM, Kuhn BR, Farr LA, et al: Behavioral therapy intervention trial to improve sleep quality and cancer-related fatigue. Psychooncology 18: 634-646, 2009
26. Benson AB, Ajani JA, Catalano RB, et al: Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22: 2918-2926, 2004
27. Richardson G, Dobish R: Chemotherapyinduced diarrhea. J Oncol Pharm Pract 13:181-198, 2007
28. National Health Service Fife Area Drug and Therapeutics Committee. Guidelines for the control of constipation in adult patients with cancer. Cancer Control 11:24-25, 2004 (suppl)
29. Avila JG: Pharmacologic treatment of constipation in cancer patients. Cancer Control 11:10-18, 2004 (suppl)
30. Dodd M, Janson S, Facione N, Faucett, et al: Advancing the science of symptom management. J Adv Nurs 33:668-676, 2001
31. National Cancer Institute. Common Toxicity Criteria: Cancer Therapy Evaluation program, version 2.0. Bethesda, MD, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, 1998
32. Zigmond AS, Snaith RT: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
33. Bjelland I, Dahl AA, Haug TT, et al: The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J Psychosom Res 52:69-77, 2002
34. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
35. Sprangers MA, Cull A, Groenvold M, et al: The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: An update and overview-EORTC Quality of Life Study Group. Qual Life Res 7:291-300, 1998
36. Fayers PM, Machin D: Quality of Life Assessment, Analysis, and Interpretation (ed 2). Chichester, United Kingdom, John Wiley, 2007
37. Rawl SM, Given BA, Given CW, et al: Intervention to improve psychological functioning for newly diagnosed patients with cancer. Oncol Nurs Forum 29:967-975, 2002
38. Peters L, Sellick K: Quality of life of cancer patients receiving inpatient and home-based palliative care. J Adv Nurs 53:524-533, 2006
39. Findlay M, von Minckwitz G, Wardley A: Effective oral chemotherapy for breast cancer: Pillars of strength. Ann Oncol 19:212-222, 2008
40. Hakamies-Blomqvist L, Luoma ML, SjöströmJ, et al: Timing of quality of life (QoL) assessments as a source of error in oncological trials. J Adv Nurs 35:709-716, 2001
41. McCabe C, Begley C, Collier S, et al: Methodological issues related to assessing and measuring quality of life in patients with cancer: Implications for patient care. Eur J Cancer Care (Engl) 17:56-64, 2008
42. Cox K, Wilson E: Follow-up for people with cancer: Nurse-led services and telephone interviews. J Adv Nurs 43:51-61, 2003
43. Beaver K, Twomey M, Witham G, et al: Meeting the information needs of women with breast cancer: Piloting a nurse-led intervention. Eur J Oncol Nurs 10:378-390, 2006